A 78-year-old man presented with omalgia and a 3-month hard-mass in his right shoulder. He didn't have any clinical history of interest.
An X-ray, a CT scan and an MRI of the right shoulder were performed, as well as an US-guided biopsy to confirm the diagnosis. It was completed with thoracoabdominopelvic CT.
The X-ray (Fig. 1) and CT (Fig. 2) showed a mixed lytic-sclerotic lesion in the distal third of the right clavicle with a spiculated sunburst periosteal reaction and a soft-tissue mass associated, which was responsible for the visible lump. MRI (Fig. 3) more precisely showed the soft-tissue component of the lesion with lobulated well-defined borders around the clavicle, which also affected the surrounding structures.
The thoracoabdominopelvic CT showed a second bone lesion in the right hemipelvis (Fig. 4). Finally, the US-guided biopsy of the clavicle’s soft tissue mass (Fig. 5) confirmed the prostatic origin.
Periosteal reaction can occasionally occur in osteoblastic metastases, specifically prostatic ones [3,4,8,9,10]. In one report, the incidence of periosteal reaction of any kind associated with prostatic bone metastases was found to be 5% [3]. Conversely, extraosseous soft-tissue masses are more common in osteolytic metastases [11,12] and are scarce in breast and prostate cancer [12].
Our patient presented a rapidly growing lump in his right clavicle, showing in the X-ray a mixed lytic-sclerotic bone lesion with sunburst periosteal reaction and an extraosseous soft-tissue mass associated. At first, these findings suggested a primary malignant bone tumour. Due to the patient’s age, it was thought to be an osteosarcoma because a second peak of incidence has been described in elder people, especially associated with previous bone diseases such as Paget’s disease.
Afterwards, we completed the study of local and distance extension of the tumour with MRI and thoracoabdominopelvic CT, respectively. This CT revealed a second bone lesion with similar characteristics in the right hemipelvis. Said finding suggested the possibility of multicentric metastatic disease versus osteosarcoma. Hence, a tumour markers blood test was made revealing an elevated PSA level of 118.00 ng/mL, compatible with prostate adenocarcinoma [13]. An ultrasound-guided biopsy of the clavicle’s soft-tissue mass confirmed the diagnosis.
When bone metastases associate an extraosseous soft-tissue mass, initial PSA levels tend to be higher and a good response to hormonotherapy is also expected [11].
Take home message: in light of a bone lesion showing aggressive radiological features (such as the aforementioned), a metastatic origin cannot be disregarded, especially in patients over 40 years of age. If osteoblastic, prostatic or breast cancer must be suspected.
Written informed patient consent for publication has been obtained.
Prostatic adenocarcinoma bone metastasis
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Patient Information: Male, 78 years old, chief complaint of right shoulder pain (for about 3 months), and a relatively hard mass palpable in the right shoulder region.
Based on the provided X-ray, CT, and MRI images, there is a mixed osteolytic-osteoblastic lesion in the right clavicle area, with uneven bone density, and a “radiating” or “sunburst” type periosteal reaction. The shape of the clavicle is destroyed, and there is a notable soft tissue mass extending beyond the bone. A similar lesion is observed in the right pelvic (iliac) region. The overall imaging appearance suggests an aggressive lesion.
Considering the patient’s age, symptoms, imaging findings (mixed osteoblastic-osteolytic lesions with radial periosteal proliferation, soft tissue mass), and laboratory results (significantly elevated PSA), along with the pathological confirmation from a soft tissue biopsy of the clavicle, the most likely diagnosis is metastatic prostate cancer.
Given the presence of bone metastases, bone fragility and fracture risk increase. Rehabilitation should be carried out cautiously under the guidance of specialists and physical therapists, with a gradual and individualized approach. Suggested key points include:
Throughout the training process, closely monitor the patient’s cardiopulmonary status and pain level to ensure safety and efficacy.
This report is based on the current imaging and clinical information for reference only and cannot replace in-person medical consultation or professional medical advice. If you have any questions or changes in condition, please seek prompt medical evaluation. Follow-up treatment and rehabilitation should be directed by a specialist’s assessment and recommendations.
Prostatic adenocarcinoma bone metastasis